Drug development

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

New listicle: Five tips on scaling up IVT for mRNA production

The success of messenger RNA or mRNA vaccines in the fight against the global SARS-CoV-2 crisis brings a new era of vaccine development. In vitro transcription, or IVT, is a complex reaction, requiring key components like an RNA polymerase, nucleotides, and a DNA template to make each mRNA. By partnering… Read More

#Editor's Choice #News

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

Listicle: Five tips on scaling up IVT for mRNA production

In this listicle, Thermo Fisher Scientific outlines five measures to help you ensure consistency in your workflow and produce reproducible, high-quality batches of IVT mRNA at scale. The success of messenger RNA (mRNA) vaccines in combatting the global SARS-CoV-2 crisis brings a new era of vaccine development. Read More

#Listicles #Videos

Patient advocacy group
#Clinical trial design #Clinical trials #Decentralised clinical trials #Drug development #Patient centricity #Rare disease

Recruiting and retaining patients for successful drug development

Craig Stevens, Senior Patient Engagement Specialist, and Amanda Henkel, VP, Strategy from MEDiSTRAVA (an Inizio Company), delve into the challenges and opportunities that surround clinical trial design for rare diseases. The drug development process requires collaboration at all stages, and is particularly important in… Read More

#Exclusive Content

#Biopharmaceuticals #Cell and gene therapy #Covid-19 #Drug development

Overcoming inefficiencies to improve access to cell and gene therapy 

The cell and gene therapy (CGT) landscape has grown significantly in the past year. Between the 24 therapies already approved by the FDA1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. Lauren Collison, PhD, Senior VP, Operations & Site Head, KBI Biopharma, reflects.  … Read More

#Exclusive Content #Opinion

#Drug development #Drug discovery #Imaging #Magnetic Resonance Imaging (MRI) #Pharmaceuticals #Technology

eBook: Imaging and drug discovery

A new eBook is now available for download. This latest eBook sponsored by Bethyl Laboratories/Fortis Life Science features expert opinions on how imaging technologies are informing drug discovery and bringing more insight into treating diseases. Download this exclusive eBook to learn more about: The importance of imaging… Read More

#News

Imaging eBook
#Drug development #Drug discovery #Imaging #Magnetic Resonance Imaging (MRI) #Pharmaceuticals #Technology

Imaging and drug discovery: Applications and innovations

This latest eBook sponsored by Bethyl Laboratories/Fortis Life Science features expert opinions on how imaging technologies are informing drug discovery and bringing more insight into treating diseases. Download this exclusive eBook to learn more about: The importance of imaging innovations in the fight against cancer How magnetic resonance imaging (MRI)… Read More

#DDW eBooks #Intelligence

#Antivirals #Drug development #Drug discovery #Henipavirus #Investment

Millions invested in antiviral medicines for future pandemics 

The partners in the Pandemic Antiviral Discovery (PAD) initiative have announced grants totalling more than $26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat henipavirus infection and disease in humans.  These grants mark the majority of the first investments to come… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Connected chemistry: Choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

Rare disease
#Clinical development #Drug development #Drug discovery #Rare disease #Rare Disease Day

What is the biggest barrier to rare disease drug development?

Dr Asma Patel, Vice President of Integrated Services for Early Development at Quotient Sciences, reflects on the biggest barriers to rare disease drug development and how companies can overcome these. Despite improvements in regulatory support and commercial rewards, difficulties remain for drug developers in bringing rare disease drugs… Read More

#Exclusive Content #Opinion

#Covid-19 #Drug development #Drug discovery #HIV #Immunity #Immunology / Virology & Vaccines #Vaccines

New episode of the DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Our news highlights this week focus on research into vaccines, with… Read More

#News

#Covid-19 #Drug development #Drug discovery #HIV #Immunity #Immunology / Virology & Vaccines #Vaccines

This week in drug discovery (20-24 February)

News round-up for 20-24 February by DDW Digital Content Editor Diana Spencer.  Our news highlights this week focus on research into vaccines, with good news for the treatment or prevention of various challenging conditions, including Covid-19, Strep A and HIV. Particularly interesting is the announcement that a new class… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Webinar: Choose the right drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#Business #Drug development #Drug discovery #Marketing #Pharmaceuticals #Regulatory

The three key stages to a successful specialty drug launch

Listen to this article on the DDW Podcast: Craig Caceci, Managing Director at Terebellum, offers guidance to pharmaceutical companies that are in the position to take their drugs to market.  In today’s competitive environment, a winning, fail-safe drug launch strategy is more important than ever, especially… Read More

#Exclusive Content #Regulatory

#AI / data analytics / healthtech / informatics #Cancer research #Collaboration #Drug development #Drug discovery #Oncology #Partnership

This week in drug discovery (13-17 February)

News round-up for 13-17 February by DDW Digital Content Editor Diana Spencer.  The drug discovery sector is feeling the love this Valentine’s week, with several new research collaborations bringing together a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Event: How to choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Webinar: Opportunities for CGT in drug development

Hosted by DDW and supported by Benchling and BPS Bioscience, Cell and gene therapy: sustaining growth and maximising opportunities will be free to attend on February 17 at 8am PST / 11am EST / 4pm GMT / 5pm CET. Cell and gene therapies (CGT) are transforming the way diseases… Read More

#News